Amiri Fatemeh, Safiri Saeid, Shamekh Ali, Ebrahimi Ali, Sullman Mark J M, Kolahi Ali-Asghar
Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Sci Rep. 2025 Feb 27;15(1):7058. doi: 10.1038/s41598-025-89899-w.
Alzheimer's disease (AD) ranks among the leading causes of morbidity and mortality worldwide. The objective was to evaluate the burden of AD and other dementias among the countries of the Middle East and North Africa (MENA) region by age and sex from 1990 to 2021. The data were sourced from the Global Burden of Disease (GBD) study 2021. The estimates are presented as counts and age-standardised rates per 100,000 accompanied by 95% uncertainty intervals (UIs). In 2021, AD and other dementias recorded an age-standardised prevalence of 772.7 per 100,000 in the MENA region (95% UI 671.2-877.6 per 100,000). This rate decreased by 4.9% in comparison to 1990, marking a statistically significant change. AD and other dementias also accounted for approximately 73.79 thousand deaths in the region in 2021, with the age-standardised rate decreasing by 8.6% compared to 1990. Moreover, the disability-adjusted life years (DALY) rate was 476.3 per 100,000 population (95% UI 225.6-1004.2), representing a 7.7% decrease from 1990 to 2021. Lebanon registered the highest point prevalence per 100,000 at 828.25, while the United Arab Emirates recorded the lowest at 652.43. The age-standardised point prevalence decreased from 1990 to 2021 in 13 of the MENA countries, while no significant changes were observed in eight of countries. Additionally, in 2021, women experienced higher prevalence rates, DALYs, compared to men. In the MENA region, age-standardised dementia prevalence rose with age in both sexes. The burden of dementia in MENA has decreased from 1990 to 2021, but it remains higher than global estimates. Furthermore, the findings indicate that dementia imposes a greater burden on the female population compared to males. To achieve a more accurate estimation of the burden of Alzheimer's disease and other dementias, more systematic studies in low- to middle-income countries within the MENA region are required.
阿尔茨海默病(AD)是全球发病和死亡的主要原因之一。目的是评估1990年至2021年中东和北非(MENA)地区各国按年龄和性别划分的AD及其他痴呆症负担。数据来源于《2021年全球疾病负担(GBD)研究》。估计数表示为每10万人的病例数和年龄标准化率,并伴有95%的不确定性区间(UI)。2021年,MENA地区AD及其他痴呆症的年龄标准化患病率为每10万人772.7例(95%UI为每10万人671.2 - 877.6例)。与1990年相比,该比率下降了4.9%,具有统计学意义。2021年,AD及其他痴呆症在该地区还导致了约73790例死亡,年龄标准化率与1990年相比下降了8.6%。此外,残疾调整生命年(DALY)率为每10万人口476.3(95%UI为225.6 - 1004.2),从1990年到2021年下降了7.7%。黎巴嫩的每10万人口时点患病率最高,为828.25,而阿拉伯联合酋长国最低,为652.43。在MENA地区的13个国家中,年龄标准化时点患病率从1990年到2021年有所下降,而8个国家未观察到显著变化。此外,2021年,女性的患病率和DALY率高于男性。在MENA地区,两性的年龄标准化痴呆患病率均随年龄增长而上升。从1990年到2021年,MENA地区的痴呆症负担有所下降,但仍高于全球估计数。此外,研究结果表明,痴呆症对女性人口的负担比对男性更大。为了更准确地估计阿尔茨海默病和其他痴呆症的负担,需要在MENA地区的低收入和中等收入国家开展更系统的研究。